Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy-Predictors and prognostic factors

Head Neck. 2018 Jul;40(7):1434-1442. doi: 10.1002/hed.25130. Epub 2018 Mar 9.

Abstract

Background: We investigated risk and prognostic factors for second primary squamous cell carcinoma (SCC) in patients with nasopharyngeal carcinoma (NPC) after radiotherapy (RT).

Methods: A total of 49 021 patients with NPC were treated at Sun Yat-Sen Cancer Center between January 1970 and December 2009. The incidence and management of second primary SCCs were analyzed.

Results: A total of 142 patients (0.29%) developed second primary SCC, with 78.2% in the upper aerodigestive tract. Older age, smoking, and chemotherapy were associated with an increased rate of second primary SCC. The 3, 5, and 10-year overall survival (OS) rates for second primary SCC were 47.18%, 31.69%, and 11.97%, respectively. Advanced age, family history of cancer, and treatment modality were independent prognostic factors for survival.

Conclusion: Second primary tumors rarely develop in patients with NPC treated with RT, but when this occurs, second primary SCC comprises a majority of these. Intensity-modulated RT may shorten the latency to second primary SCC. Surgery as the first-line treatment may improve survival and prognosis.

Keywords: nasopharyngeal carcinoma; radiotherapy; second primary squamous cell carcinoma; second primary tumor; treatment.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Antineoplastic Agents / adverse effects
  • Carcinoma, Squamous Cell / mortality*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy*
  • China / epidemiology
  • Combined Modality Therapy
  • Female
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / mortality
  • Nasopharyngeal Neoplasms / pathology
  • Nasopharyngeal Neoplasms / radiotherapy*
  • Neoplasms, Second Primary / mortality*
  • Neoplasms, Second Primary / pathology
  • Neoplasms, Second Primary / therapy
  • Prognosis
  • Retrospective Studies
  • Smoking / adverse effects
  • Young Adult

Substances

  • Antineoplastic Agents